Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2020	Jan. 31, 2019
Current assets:
Cash and cash equivalents	$ 124,024	$ 127,875
Accounts receivable, net of allowance for doubtful accounts of $810 and $2,360 as of January 31, 2020 and January 31, 2019, respectively	37,128	33,538
Investments	227,375	0
Deferred contract costs, current	9,301	6,002
Prepaid expenses and other current assets	7,163	5,422
Total current assets	404,991	172,837
Property and equipment, net	12,369	5,772
Deferred contract costs, non-current	16,387	11,470
Other assets	1,651	7,155
Total assets	435,398	197,234
Current liabilities:
Accounts payable	6,434	7,657
Accrued expenses and other current liabilities	7,197	7,145
Accrued compensation	13,911	10,050
Deferred revenue, current	87,490	63,957
Total current liabilities	115,032	88,809
Deferred revenue, non-current	5,079	147
Other liabilities	7,349	4,185
Total liabilities	127,460	93,141
Commitments and contingencies (Note 5)
Redeemable convertible preferred stock, $0.000005 par value per share: 100,000,000 and 41,810,231 shares authorized, as of January 31, 2020 and 2019; no shares issued and outstanding as of January 31, 2020; 41,273,345 shares issued and outstanding as of January 31, 2019; liquidation preference of $203,861 as of January 31, 2019	0	173,023
Stockholders’ equity (deficit):
Common stock, $0.000005 par value per share: 1,000,000,000 and 85,000,000 shares authorized as of January 31, 2020 and 2019, respectively; 77,793,540 and 23,189,921 shares issued and outstanding as of January 31, 2020 and 2019, respectively	0	0
Additional paid-in capital	487,008	59,938
Accumulated other comprehensive income	137	0
Accumulated deficit	(179,207)	(128,868)
Total stockholders’ equity (deficit)	307,938	(68,930)
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$ 435,398	$ 197,234